Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 45 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT02141074
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
- Locations
-
- Miller Children's Hospital Long Beach Long Beach, California, United States
- Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
- Shands Hospital at the University of Florida Gainesville, Florida, United States
- Nemours Chld Clnc Jacksonville Jacksonville, Florida, United States
NCT01467427
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
- Locations
-
- Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
- UC Davis Medical Center Sacramento, California, United States
- Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
- Childrens National Medical Ctr Washington D.C., District of Columbia, United States
NCT02137850
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Arizona H&T Phoenix Child Hosp Phoenix, Arizona, United States
- Miller Children's Hospital Long Beach Long Beach, California, United States
- Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States
- Children's Hosp Of Orange Orange, California, United States
NCT01561391
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site New Orleans, Louisiana, United States
NCT01830712
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States
NCT03075670
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Peoria, Illinois, United States
- Novo Nordisk Investigational Site East Lansing, Michigan, United States
NCT03528551
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site New Orleans, Louisiana, United States
NCT03196284
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Indianapolis, Indiana, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site Vienna, Austria
NCT01493778
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Sacramento, California, United States
- Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
NCT01731600
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
NCT01480180
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Sacramento, California, United States
- Novo Nordisk Investigational Site Torrance, California, United States
NCT01489111
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Long Beach, California, United States
- Novo Nordisk Investigational Site Sacramento, California, United States
- Novo Nordisk Investigational Site Torrance, California, United States
NCT02035384
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Mobile, Alabama, United States
- Novo Nordisk Investigational Site Torrance, California, United States
- Novo Nordisk Investigational Site Peoria, Illinois, United States
- Novo Nordisk Investigational Site Albuquerque, New Mexico, United States
NCT02994407
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Orlando, Florida, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site East Lansing, Michigan, United States
- Novo Nordisk Investigational Site Cleveland, Ohio, United States
NCT01862367
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
- Novo Nordisk Investigational Site Detroit, Michigan, United States
NCT02941354
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
- Locations
-
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Peoria, Illinois, United States
- Novo Nordisk Investigational Site Memphis, Tennessee, United States
- Novo Nordisk Investigational Site Richmond, Virginia, United States
NCT02541942
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Tucson, Arizona, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
NCT00951405
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Little Rock, Arkansas, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
NCT01395810
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site San Francisco, California, United States
- Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
- Novo Nordisk Investigational Site Jacksonville, Florida, United States
NCT00978380
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Orange, California, United States
- Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
- Novo Nordisk Investigational Site Tampa, Florida, United States
- Novo Nordisk Investigational Site Atlanta, Georgia, United States